Byron Creese

Publications

• The cognitive profile of middle‐aged and older adults with high vs. low autistic traits
• A DATA-DRIVEN EXAMINATION OF APATHY AND DEPRESSIVE SYMPTOMS IN DEMENTIA WITH INDEPENDENT REPLICATION
• Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 Update
• Epigenetic insights into neuropsychiatric and cognitive symptoms in Parkinson’s disease: A DNA co-methylation network analysis
• Epigenetic insights into neuropsychiatric and cognitive symptoms in Parkinson's disease: A DNA co-methylation network analysis
• The impact of the COVID‐19 pandemic on cognitive health
• A biopsychosocial interpretation of the Neuropsychiatric Inventory – Nursing Home assessment: reconceptualising psychiatric symptom attributions
• Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's Disease.
• Loneliness, physical activity and mental health during Covid-19: a longitudinal analysis of depression and anxiety in adults over 50 between 2015 and 2020.
• FLAME: A computerized neuropsychological composite for trials in early dementia.
• Psychosis in Alzheimer's Disease.
• Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effects.
• Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease
• The mental and physical health profiles of older adults who endorse elevated autistic traits.
• Sleep problems and mental health difficulties in older adults who endorse high autistic traits
• Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease
• Psychosis in Alzheimer disease — mechanisms, genetics and therapeutic opportunities
• Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease
• Traumatic life experiences and post‐traumatic stress symptoms in middle‐aged and older adults with and without autistic traits
• Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease
• Neuropsychiatric symptoms in AD: the search for mechanisms
• Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease
• Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for Alzheimer’s disease
• Late-life Onset Psychosis-like Symptoms Assessed in the Mild Behavioral Impairment Framework are Associated Impaired Performance on the Stroop Task
• Amidst an amygdala renaissance in Alzheimer's disease.
• The relationship between playing musical instruments and cognitive trajectories: Analysis from a UK ageing cohort.
• Is lifetime traumatic brain injury a risk factor for mild cognitive impairment in veterans compared to non-veterans?
• The Canadian platform for research online to investigate health, quality of life, cognition, behaviour, function, and caregiving in aging (CAN-PROTECT): study protocol, platform description, and preliminary analyses
• Proof-of-concept recall-by-genotype study of extremely low and high Alzheimer's polygenic risk reveals autobiographical deficits and cingulate cortex correlates.
• Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
• Self-reported sleep fragmentation and sleep duration and their association with cognitive function in PROTECT, a large digital community-based cohort of people over 50.
• Cognitive decline in older adults in the UK during and after the COVID-19 pandemic: a longitudinal analysis of PROTECT study data.
• Optimizing detection of Alzheimer's disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO.
• Sativex® for the treatment of Agitation & Aggression in Alzheimer’s Dementia in UK nursing homes (STAND): Protocol for a feasibility randomised controlled trial
• Investigating the genetic relationship between depression symptoms and Alzheimer’s Disease in clinically diagnosed and proxy cases
• Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease.
• Lifetime Traumatic Brain Injury and Cognitive Domain Deficits in Late Life: The PROTECT-TBI Cohort Study.
• Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status.
• A data-driven examination of apathy and depressive symptoms in dementia with independent replication.
• Latent subtypes of manic and/or irritable episode symptoms in two population-based cohorts.
• Healthcare utilisation, physical activity and mental health during COVID-19 lockdown: an interrupted time-series analysis of older adults in England.
• Identification of a sex-specific genetic signature in dementia with Lewy bodies: a meta-analysis of genome-wide association studies
• Self-harm and Suicidality Experiences of Middle-Age and Older Adults With vs. Without High Autistic Traits.
• Are subtypes of affective symptoms differentially associated with change in cognition over time: A latent class analysis.
• Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.
• Gender/Sex Differences in the Association of Mild Behavioral Impairment with Cognitive Aging.
• Healthcare utilisation and physical activities for older adults with comorbidities in the UK during COVID-19.
• Risky drinking and cognitive impairment in community residents aged 50 and over.
• Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults.
• A longitudinal study of late-life psychosis and incident dementia and the potential effects of race and cognition